LS Investment Advisors’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-4,759
Closed -$147K 1208
2020
Q2
$147K Hold
4,759
0.01% 850
2020
Q1
$131K Hold
4,759
0.01% 795
2019
Q4
$139K Sell
4,759
-6,138
-56% -$146K 0.01% 990
2019
Q3
$208K Hold
10,897
0.01% 768
2019
Q2
$239K Buy
10,897
+1,701
+18% +$37.3K 0.01% 701
2019
Q1
$188K Buy
+9,196
New +$160K 0.01% 820

Other funds holding NEO

LS Investment Advisors's NEO Position: Q3 2020 in Review

LS Investment Advisors sold out of NeoGenomics (NEO) in Q3 2020, closing a stake of 4,759 shares — an estimated $147K sold.

LS Investment Advisors first reported a position in NEO in Q1 2019 and held it in 6 quarters. The position peaked at $239K in Q2 2019. 294 funds tracked by Wall St. Rank hold NEO as of Q3 2020.

  • LS Investment Advisors reported no remaining NeoGenomics position as of Q3 2020 after selling out during the quarter.
  • LS Investment Advisors sold 4,759 NeoGenomics shares in Q3 2020, an estimated $147K.
  • LS Investment Advisors first reported a position in NeoGenomics in Q1 2019 and held it in 6 quarters.
  • LS Investment Advisors's NeoGenomics position peaked at $239K in Q2 2019.
  • 294 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2020.

Based on LS Investment Advisors's 13F filing for Q3 2020, filed 12 Nov 2020.